Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies
Sign Up to like & getrecommendations! Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.158444
Abstract: New strategies that augment T cell responses are required to broaden the therapeutic arsenal against cancer. CD96, TIGIT, and CD226 are receptors that bind to a communal ligand, CD155, and transduce either inhibitory or activating… read more here.
Keywords: activity anti; cd96; cross linking; cd96 antibodies ... See more keywords